Business Profile & Competitive Position
AMETEK, Inc. operates in the Industrials sector within the Electrical Equipment & Parts industry, functioning essentially as a multi-industrial manufacturer of electronic instruments and electromechanical devices. Its operations are organized into two groups: Electronic Instruments (EIG), which designs advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets; and Electromechanical (EMG), which supplies precision motion control solutions, engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects. This structure means AMETEK is not a single-product company but rather a collection of niche engineered-component and instrumentation businesses serving capital-intensive end markets.
The margin and return figures provide a quantitative read on how defensible that model is. The company reported a 20.0% net margin and 14.5% return on equity, ratios that typically point to differentiated products, pricing discipline or cost advantages rather than commodity-style competition. In 2025 AMETEK delivered sales of $7,401.1 million, up 6.6% from 2024, with record operating income, net income, orders and backlog. A business that can grow the top line while sustaining a 20% net margin implies that its niche instrumentation and precision-engineering franchises carry meaningful pricing power, even if the broader industrial economy remains cyclical.
Financial Posture
Against a market capitalization of $54.5 billion, AMETEK trades at a P/E of 34.6, supported by net margins of 20.0%, ROE of 14.5% and a beta of 0.99. The valuation multiple is the highest-yielding financial signal here, because a 34.6x P/E sits well above a typical diversified-industrial median and implies the market is paying a premium for earnings quality, growth consistency or both. The 20.0% net margin validates some of that premium, but investors also need to weigh whether forward EPS growth can keep the multiple from compressing.
The beta of 0.99 means the stock has exhibited roughly market-level volatility, which is notable for an industrial name and suggests it has not traded like a deep cyclical. ROE of 14.5% is solid but not extraordinary, indicating that the company reinvests capital productively without overleveraging to inflate returns. As of the current snapshot, AMETEK shares were at $237.72, with the 50-day exponential moving average at $240.27 and the RSI at 45.1, a neutral-to-slightly-weak near-term technical posture.
Strategic Priorities & Outlook
AMETEK's most recent 10-K outlines a strategy built around what it calls the AMETEK Growth Model: high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Those targets are not abstract mission statements; the 2025 results showed 6.6% sales growth and 7.9% diluted EPS growth to $6.40, with record backlog suggesting the growth model remains on track operationally.
The company explicitly emphasizes Operational Excellence through lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and increasingly through digitalization and artificial intelligence. That focus on process improvement is part of how it preserves the 20.0% net margin while absorbing acquisitions.
Acquisitions are the third pillar. Between 2021 and December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. The 2025 deals were particularly large: it spent $933.2 million in cash, net of cash acquired, to buy Kern, a provider of high-precision machining and optical inspection solutions, and FARO Technologies, which adds 3D measurement and imaging capabilities. The 10-K also notes the company maintains best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, a footprint designed for customer proximity and international expansion. In 2025, 52% of EIG's net sales and 42% of EMG's net sales were to customers outside the United States. AMETEK employed approximately 22,500 people as of December 31, 2025.
Macro & Geopolitical Exposure
As an Electrical Equipment & Parts business in the Industrials sector, AMETEK is exposed to the global capital-spending cycle. Aerospace and defense budgets, power-generation investment, industrial automation adoption and medical-device demand all flow through its revenue base. Because a significant share of its sales are non-U.S., currency translation can also move reported results quarter to quarter and year to year.
More specifically, the industry classification implies exposures to trade policy, tariffs and supply-chain restructuring for precision components and specialty metals. A company with manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia may benefit from diversified sourcing but also faces tariff, sanctions and geopolitical risk across several jurisdictions. Semiconductor availability, raw-material prices and energy costs can affect margins in the Electrical Equipment & Parts space broadly, even if AMETEK's niche positioning provides some insulation through long-term customer programs.
Recent Developments
Recent headlines capture both deal activity and a near-term pullback in sentiment. On September 4, 2026, Seeking Alpha covered Baron SMID Cap ETF's second-quarter 2026 portfolio activity, while a September 3, 2026 Zacks piece asked why AMETEK was down 8.5% since its last earnings report. A September 1, 2026 Seeking Alpha article framed AMETEK as "The Quiet Control Layer Behind The Next Industrial Investment Cycle," highlighting the company's positioning in industrial instrumentation and automation. On August 26, 2026, AMETEK announced through PR Newswire that it had completed the acquisition of Indicor Instrumentation, continuing the M&A cadence described in the 10-K. The 8.5% decline referenced by Zacks is worth noting because it stands in contrast to the company's strong fundamental track record and may reflect valuation compression, broader industrial sentiment or positioning ahead of the next earnings report rather than operational deterioration.
Earnings Behavior & Post-Earnings Drift
AMETEK has been one of the more consistent earnings performers in the industrial space: over the last eight reported quarters it beat consensus on all eight occasions, a 100% beat rate, with an average earnings surprise of 4%. Yet the post-earnings price response has been muted. The average five-day move following those eight reports was 0.46%, classified as "flat" drift, meaning the market has generally priced in the beats quickly and not rewarded them with sustained follow-through.
The most recent four quarters illustrate that pattern. On August 4, 2026, AMETEK reported $2.09 EPS versus a $1.99 estimate, a 5% beat; the stock rose 0.28% the next day and 0.89% over the following five sessions. On April 30, 2026, it reported $1.97 versus $1.90, a 3.7% beat, yet the stock fell 2.13% the next day and 0.33% over five days. The February 3, 2026 report showed $2.01 versus $1.94, a 3.6% beat, producing a 0.48% next-day decline but a 1.83% gain over five days. The October 30, 2025 report delivered $1.89 versus $1.76, a 7.4% beat, with the stock rising 1.91% the next day before sliding 0.54% over the following five days.
Next on the calendar is the October 29, 2026 before-market-open report, with the consensus EPS estimate at $2.11. The 100% beat streak and 4% average surprise provide historical context, but the flat post-earnings drift suggests that beating estimates has not by itself generated meaningful near-term alpha. Instead, post-earnings reactions may hinge more on forward guidance, order commentary and how the market is positioned going into the print.
For a deeper perspective on how institutional analysts and quantitative models currently weigh AMETEK's valuation, earnings consistency and M&A-driven growth profile, consult the full institutional verdictavailable on the platform.
Frequently Asked Questions
What does AMETEK actually manufacture?
AMETEK is an industrial manufacturer of electronic instruments and electromechanical devices. Its Electronic Instruments segment makes analytical, test and measurement instruments for process, aerospace, power and industrial markets, while its Electromechanical segment supplies precision motion control, medical components, thermal management systems, specialty metals and electrical interconnects.
How consistently has AMETEK beaten earnings expectations?
Over the last eight reported quarters, AMETEK beat consensus EPS estimates in all eight, a 100% beat rate, with an average earnings surprise of 4%. The last four beats ranged from 3.6% to 7.4% above estimates.
Does AMETEK stock typically rise after it beats earnings?
Not strongly. Despite the perfect beat rate, the average five-day post-earnings move across the last eight quarters was only 0.46%, classified as flat drift. Individual reactions have varied, including a 2.13% next-day drop after the April 2026 beat, suggesting that good results are often priced in quickly.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-04 | $2.09 | $1.99 | +5% | +0.28% | +0.89% |
| 2026-04-30 | $1.97 | $1.9 | +3.7% | -2.13% | -0.33% |
| 2026-02-03 | $2.01 | $1.94 | +3.6% | -0.48% | +1.83% |
| 2025-10-30 | $1.89 | $1.76 | +7.4% | +1.91% | -0.54% |
| 2025-07-31 | $1.78 | $1.69 | +5.3% | - | - |
| 2025-05-01 | $1.75 | $1.69 | +3.6% | - | - |
Previous AME editions
Get the institutional verdict on AME
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the AME verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.